Introduction
The TruLife Distribution lawsuit was a commercial dispute filed in 2022 between Nutritional Products International (NPI) and TruLife Distribution Inc., along with its CEO, Brian Gould. The case focused on competition-related issues and alleged misuse of business information.
This was not a consumer case. It was a dispute between two companies operating in the same industry, where one side claimed that the other had used protected business knowledge and engaged in improper competitive practices.
Companies Involved
NPI and TruLife Distribution both operated in product distribution and brand expansion services. Their overlapping services created direct competition in the market.
TruLife Distribution presents itself as a company that helps brands grow in retail markets. More details about the company can be found here:
TruLife Distribution official website — https://trulifedist.com/
Key Individuals
Name: Brian Gould
Position: CEO of TruLife Distribution
In the lawsuit, it was stated that he had a prior association with NPI before leading TruLife Distribution. This prior connection was central to the claims made in the case.
Reason the Lawsuit Was Filed
NPI filed the lawsuit based on the claim that TruLife Distribution was not operating independently, but instead relied on internal knowledge, data, and business methods that originated from NPI.
The dispute was framed as more than normal competition. It was presented as competition supported by information that should have remained confidential.
Main Allegations
1. Trade Secret Misuse
NPI claimed that confidential business materials were used without permission. These included:
- Client-related information
- Internal strategies
- Business development processes
The claim was that this information was not public and had been developed within NPI.
2. Breach of Fiduciary Duty
It was alleged that while still connected to NPI, actions were taken that led to the formation of a competing business. According to the claim, this violated obligations owed during that time.
3. Use of Confidential Business Information
The lawsuit stated that internal operational systems and methods were used after moving into a competing company. These were described as non-public and proprietary.
4. Misleading Marketing Representation
NPI also alleged that TruLife Distribution presented marketing material in a way that could create confusion. This included:
- Case studies without clear attribution
- Business results presented in a way that may not clearly identify their origin
5. Unfair Competition
The final major claim was that TruLife gained an advantage in the market through the actions described above. NPI argued that this affected its own business and client relationships.
See also: Upgrading Old Plumbing: When It’s Time and Why It Matters
Allegations Summary (Copy-Friendly Table)
- Trade Secret Misuse
- Alleged use of confidential client data and strategies
- Breach of Fiduciary Duty
- Alleged planning of competing business during prior association
- Confidential Information Use
- Alleged use of internal systems and processes
- Misleading Marketing
- Case studies and results presented without clear attribution
- Unfair Competition
- Alleged client diversion and market impact
Case Timeline (Copy-Friendly)
May 2022
- Lawsuit filed by Nutritional Products International
June 2022
- Voluntary dismissal submitted
June 2022
- Case officially closed
Legal Status
The case did not go to trial. It was dismissed voluntarily by the plaintiff.
This means:
- No court ruling was issued
- No allegations were legally proven
- No penalties were assigned
All claims remained allegations without a final judgment.
Nature of the Dispute
This case was centered on business competition and the movement of an individual from one company to another within the same industry.
The main issue raised was whether confidential information and internal business methods were used in building and operating a competing company.
Conclusion
The TruLife Distribution lawsuit was a business conflict involving allegations of trade secret misuse, fiduciary breach, confidential information use, misleading marketing, and unfair competition.
Since the case ended before trial, there was no legal determination confirming or rejecting these claims. The dispute remains defined by the allegations that were presented at the time of filing.
